Development and validation of an immunoassay for quantification of NCAM-1 in human plasma

被引:2
|
作者
Guven, Arcan [1 ]
Gray, Kayleigh [1 ]
Peng, Kuan-Wei [1 ]
Klotz, Allison [1 ]
Kellogg, Mark D. [1 ,2 ,3 ]
Narain, Niven R. [1 ]
Kiebish, Michael A. [1 ]
机构
[1] BERG, 500 Old Connecticut Path, Framingham, MA 01701 USA
[2] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA
[3] Boston Childrens Hosp, Dept Lab Med, 300 Longwood Ave, Boston, MA 02115 USA
关键词
NCAM-1; Biomarker; Assay development; Assay validation; Immunoassay; Ligand binding assay; NK CELL; CD56; LEUKEMIA; ANTIGEN; EXPRESSION;
D O I
10.1016/j.jpba.2021.113981
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Background: Neural Cell Adhesion Molecule 1 (NCAM-1), a multifunctional member of the immunoglobulin superfamily, is expressed on the surface of neurons, glia, skeletal muscle, and natural killer cells. NCAM-1 has been implicated as having a role in cell-cell adhesion, involved in development of the nervous system, and for cells involved in the expansion of T cells and dendritic cells which play an important role in immune surveillance. Sensitive and specific methods to quantify non-surface bound NCAM-1 are not available. Method: A sandwich ligand binding assay was developed for quantification of NCAM-1 in plasma and validated using an electro-chemiluminescent (ECL) technology. Results: The data presented here demonstrated that the validated method met all prespecified criteria for precision, linearity, and accuracy in the range of 62.5 ng/mL to 4000.0 ng/mL, the range believed to be most relevant for plasma. The bioanalytical validation of the assay established the inter-assay coefficient of variation <8 % for calibration points, <2 % for high quality control (HQC), <8 % for medium quality control (MQC) and <19 % for low quality control (LQC) samples. Purified NCAM-1 spike-recovery experiment in plasma was used to determine assay accuracy; nominal concentrations (%) of NCAM-1 ranged from 91 % to 112 % for high and low spike level, respectively. Assay performance was subsequently evaluated for parallelism, selectivity, interference, and stability. Conclusion: NCAM-1 assay has been developed and validated in human plasma and met all assay validation parameters pre-determined during development. Clinical testing of human plasma samples indicated that NCAM-1 does not seem to be influenced by age and was slightly influenced by gender. NCAM-1 assay has potential to be used as a biomarker assay once the assay is subjected to appropriate clinical assessment and diagnostic thresholds are established. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] NCAM-1 regulates electrical impulses in Purkinje cells
    不详
    DEVELOPMENT, 2021, 148 (11):
  • [2] Development and Validation of Method for Quantification of Amisulpride in Human Plasma
    Chatterjee, B.
    Das, A.
    Chakraborty, U. S.
    Bhaumik, U.
    Sengupta, P.
    Pal, T. K.
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2008, : 235 - 238
  • [3] Development and validation of a simple, sensitive enzyme immunoassay (EIA) for quantification of prolactin in buffalo plasma
    Roy, K. S.
    Prakash, B. S.
    THERIOGENOLOGY, 2007, 67 (03) : 572 - 579
  • [4] Development and validation of a chromatographic method for quantification of rasagiline in human plasma
    Bilal, Rabiea
    Usman, Muhammad
    Khan, Abdul Muqeet
    Latif, Waqas
    Ahmad, Naseem Saud
    Riffat, Sualeha
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2018, 17 (11) : 2243 - 2248
  • [5] Development and validation of an HPLC method for quantification of dolutegravir in human plasma
    Li, Dongsheng
    Fu, Qiang
    Du, Xiaoli
    Li, Taisheng
    BIOMEDICAL CHROMATOGRAPHY, 2023, 37 (10)
  • [6] Effects of ganoderma lucidum spores powder on expression of NCAM-1 and NCAM-L1 in hippocampus of rats with epilepsy
    Wang, Shu-Qiu
    Kang, Yu-Ming
    Qi, Zong-Chun
    Ma, Xiao-Ru
    Liang, Yan-Feng
    Li, Dian-Gang
    Zhang, Bo
    FASEB JOURNAL, 2010, 24
  • [7] Development and validation of a novel immunoassay for the quantification of the major celery allergen, Api g 1
    Oliver, M. A.
    Filep, S.
    Smith, B.
    Black, Reid K.
    Cullinane, A.
    Thorpe, C.
    Chapman, M. D.
    Hindley, J. P.
    ALLERGY, 2020, 75 : 538 - 538
  • [8] Development and validation of a corticosterone enzyme immunoassay for rat plasma
    Cakan, Pinar
    Ozgocer, Tuba
    Yildiz, Sedat
    ACTA PHYSIOLOGICA, 2016, 217 : 76 - 77
  • [9] Development and validation of an HPLC-UV method for lapatinib quantification in human plasma
    Escudero, Vanesa
    Valenzuela, Bel
    Rebollo, Joseba
    Sureda, Manuel
    Brugarolas, Antonio
    CANCER RESEARCH, 2012, 72
  • [10] Development and validation of an HPLC-UV method for iodixanol quantification in human plasma
    Chitnis, Shripad D.
    Akhlaghi, Fatemeh
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 869 (1-2): : 133 - 137